Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 619.2M | $ -72.6M | -11.72% |
3/31/2025 | $ 670.6M | $ -46.6M | -6.95% |
12/31/2024 | $ 571.4M | $ -198.9M | -34.81% |
9/30/2024 | $ 587.5M | $ -308.6M | -52.53% |
6/30/2024 | $ 602.3M | $ -323.4M | -53.69% |
3/31/2024 | $ 612.3M | $ -354.8M | -57.95% |
12/31/2023 | $ 663.2M | $ -367.3M | -55.38% |
9/30/2023 | $ 461.2M | $ -295.4M | -64.05% |
6/30/2023 | $ 468.1M | $ -297.6M | -63.58% |
3/31/2023 | $ 516M | $ -301M | -58.33% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for ARVINAS INC is calculated as follows: Net Inc. Cmn. [ $ -98.83M ] / Inv. Capital [ $ 209.41M ]
(=) ROIC [ -47.2% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.38% |
std | 15.18% |